Literature DB >> 19956455

Do depressed patients with diabetes experience more side effects when treated with CitalopramThan their counterparts without diabetes? a STAR*D study.

Charlene Bryan1, Thomas Songer, Maria Mori Brooks, Michael E Thase, Bradley Gaynes, Michael Klinkman, G K Balasubramani, A John Rush, Madhukar H Trivedi, Maurizio Fava, Stephen R Wisniewski.   

Abstract

OBJECTIVE: Diabetes mellitus (DM) is often comorbid with major depressive disorder, yet the impact and types of side effects experienced by patients with DM receiving antidepressant treatment have not been examined. This study examined antidepressant treatment side effects in depressed patients with and without DM to determine whether side effects differed between groups.
METHOD: From July 2001 through April 2004, the Sequenced Treatment Alternatives to Relieve Depression study enrolled 2,876 outpatients with DSM-IV major depressive disorder from primary and psychiatric care settings. The current study compared participants with and without DM regarding frequency, intensity, and burden of side effects-using the Frequency, Intensity, and Burden of Side Effects Rating (FIBSER)-and types of side effects experienced when treated with citalopram (12-14 weeks, 20-60 mg/d).
RESULTS: There was no statistically significant difference in the maximum rating of side effects during treatment between participants with and without DM. At the last clinic visit, participants with DM reported fewer and less intense side effects and less impairment from side effects than those without DM (after adjustment for confounding effects of age, race, Hispanic ethnicity, employment status, family history of depression, anxious depression, atypical depression, age at first major depressive episode, and length of illness). However, those with DM had more side effect symptoms consistent with the diagnosis of DM (eg, blurred vision and tremors).
CONCLUSIONS: Participants with DM reported experiencing side effects at lower rates than those without DM. After statistical adjustment, the groups did not differ significantly regarding types of side effects experienced.

Entities:  

Year:  2009        PMID: 19956455      PMCID: PMC2781029          DOI: 10.4088/PCC.08m00696

Source DB:  PubMed          Journal:  Prim Care Companion J Clin Psychiatry        ISSN: 1523-5998


  42 in total

1.  Clinical and demographic factors associated with DSM-IV melancholic depression.

Authors:  Ahsan Y Khan; Joe Carrithers; Sheldon H Preskorn; Rex Lear; Stephen R Wisniewski; A John Rush; Diane Stegman; Colleen Kelley; Karen Kreiner; Andrew A Nierenberg; Maurizio Fava
Journal:  Ann Clin Psychiatry       Date:  2006 Apr-Jun       Impact factor: 1.567

2.  Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.

Authors:  Madhukar H Trivedi; A John Rush; Stephen R Wisniewski; Andrew A Nierenberg; Diane Warden; Louise Ritz; Grayson Norquist; Robert H Howland; Barry Lebowitz; Patrick J McGrath; Kathy Shores-Wilson; Melanie M Biggs; G K Balasubramani; Maurizio Fava
Journal:  Am J Psychiatry       Date:  2006-01       Impact factor: 18.112

Review 3.  Side effects of antidepressants: an overview.

Authors:  Elias A Khawam; Georgia Laurencic; Donald A Malone
Journal:  Cleve Clin J Med       Date:  2006-04       Impact factor: 2.321

4.  Development of a rating scale for primary depressive illness.

Authors:  M Hamilton
Journal:  Br J Soc Clin Psychol       Date:  1967-12

5.  Maximizing the adequacy of medication treatment in controlled trials and clinical practice: STAR(*)D measurement-based care.

Authors:  Madhukar H Trivedi; A John Rush; Bradley N Gaynes; Jonathan W Stewart; Stephen R Wisniewski; Diane Warden; Louise Ritz; James F Luther; Diane Stegman; Joanne Deveaugh-Geiss; Robert Howland
Journal:  Neuropsychopharmacology       Date:  2007-04-04       Impact factor: 7.853

6.  Association of depression and diabetes complications: a meta-analysis.

Authors:  M de Groot; R Anderson; K E Freedland; R E Clouse; P J Lustman
Journal:  Psychosom Med       Date:  2001 Jul-Aug       Impact factor: 4.312

7.  Depression and diabetes symptom burden.

Authors:  Evette J Ludman; Wayne Katon; Joan Russo; Michael Von Korff; Gregory Simon; Paul Ciechanowski; Elizabeth Lin; Terry Bush; Edward Walker; Bessie Young
Journal:  Gen Hosp Psychiatry       Date:  2004 Nov-Dec       Impact factor: 3.238

8.  A comparison of baseline sociodemographic and clinical characteristics between major depressive disorder patients with and without diabetes: a STAR*D report.

Authors:  Charlene J Bryan; Thomas J Songer; Maria Mori Brooks; Michael E Thase; Bradley N Gaynes; Michael Klinkman; A John Rush; Madhukar H Trivedi; Maurizio Fava; Stephen R Wisniewski
Journal:  J Affect Disord       Date:  2007-11-26       Impact factor: 4.839

9.  The Pathways Study: a randomized trial of collaborative care in patients with diabetes and depression.

Authors:  Wayne J Katon; Michael Von Korff; Elizabeth H B Lin; Greg Simon; Evette Ludman; Joan Russo; Paul Ciechanowski; Edward Walker; Terry Bush
Journal:  Arch Gen Psychiatry       Date:  2004-10

10.  The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R).

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Doreen Koretz; Kathleen R Merikangas; A John Rush; Ellen E Walters; Philip S Wang
Journal:  JAMA       Date:  2003-06-18       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.